Emotional Awareness and SElf-regulation for Depression in Patients With Hypertension (EASE) Study
Hypertension

About this trial
This is an interventional treatment trial for Hypertension focused on measuring Hypertension, Coping, Relaxing
Eligibility Criteria
Inclusion Criteria:
- Diagnosis of hypertension based on the criteria in the ICD-9/-10
- Mild to moderate depressive symptoms (PHQ-9 ≥ 5)
- English-speaking
- If taking depression medications, medications must stable for the past 6 weeks (no change to type or dose)
- Willing to provide informed consent, be audio-recorded, and comply with all other aspects of protocol
Exclusion Criteria:
- Moderate to severe depressive symptoms (PHQ-9 ≥ 15)
- Current substance abuse
- Current eating disorder
- Self-harm within the past 3 months
- Current obsessive-compulsive disorder
- Current anxiety disorder (e.g., PTSD, panic disorder)
- Active suicidal ideation
- History of or current diagnosis of psychosis
- Significant cognitive impairment (mini mental state examination score ≤ 20)
- History of previous training in mindfulness
- History of more than 8 sessions of cognitive behavioral therapy
- Counseling more frequently than once per month
Sites / Locations
- New York University Medical Center
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
UPLIFT
Usual Care
Eligible participants will complete 8 weekly group sessions by phone. The intervention builds cognitive-behavioral and mindfulness skills to help reduce depressive symptoms. Each hour-long weekly session consists of: check-in, instruction, skill building, discussion, and a home-based practice assignment.
Subjects randomized to UC will be advised to seek help from their primary care physician (PCP) or other sources as they normally would if they encountered symptomatic deterioration or other difficulties over the course of the study. All treatments received over the course of the study for the UC group and outside of the study (for the intervention group) will be assessed at each time point.